Skip to main content

Table 2 Differential expression of circulating HCMV-encoded miRNAs under various disease conditions

From: Altered human cytomegalovirus-encoded miRNAs in host circulation: novel disease biomarkers and potential aetiological agents

HCMV-encoded miRNA

Sample type

Diseases

Alteration

References

hcmv-miR-UL112

Plasma

Essential hypertension

Upregulation

[32]

Plasma

Type 2 diabetes

Upregulation

[81]

Plasma

Glioblastoma

Upregulation

[81]

hcmv-miR-US5-1, hcmv-miR-US-5-2-3p, hcmv-miR-UL-22a-5p, hcmv-miR-US25-1-5p, hcmv-miR-US-25-2-3p, hcmv-miR-US-25-2-5p, hcmv-miR-US-33-3p, hcmv-miR-UL36-5p, hcmv-miR-UL112-3p

Blood

Solid organ transplantation

Upregulation

[83]

hcmv-miR-US25-1-5p, hcmv-miR-US25-2-5p

Plasma

Congenital CMV infection

Upregulation

[84]

hcmv-miR-US33-5p

Plasma

Acute aortic dissection

Upregulation

[86]

hcmv-miR-US4-1, hcmv-miR-UL-148D

Serum

IFNα treatment non-responsive chronic hepatitis B

Upregulation

[87]

hcmv-miR-UL112-3p, hcmv-miR-UL22a-5p, hcmv-miR-UL148d, hcmv-miR-UL36-5p, hcmv-miR-UL59

Serum

Oral lichen planus

Upregulation

[35]